Heat shock proteins, a highly conserved family of molecular chaperones found in both eukaryotes and prokaryotes, are emerging as central players in cancer biology, according to a review published in Discover Oncology. Their expression is mostly induced by heat shock or other stressors, and based on molecular weight the family is divided into HSP110, HSP90, HSP70, HSP60, HSP40, and the small heat shock proteins. The review, authored by Yue Yu, Su Li, Hao-ran Fan, and Chen-chen Zhou, gathers recent literature on how these proteins regulate tumor behavior and how they might be exploited for diagnosis, tumor staging, and targeted drug design.
The authors report that heat shock proteins and exosomes carrying them are present in a variety of tumors and their surrounding microenvironments. Within that microenvironment, the review highlights three major contexts in which the proteins act: hypoxic conditions, immune components, and immunosuppressive components.
Beyond the microenvironment, the review assigns heat shock proteins significant roles in several hallmark processes of cancer. These include tumor proliferation, apoptosis, epithelial-mesenchymal transition, angiogenesis, metastasis, and immune escape.
A key point emphasized by the authors is the dual nature of these proteins. Heat shock proteins not only have inhibitory effects on tumors, but also promote the occurrence and development of tumor cells under specific conditions.
The review therefore treats heat shock proteins as context-dependent regulators rather than simple targets.
To that end, the article attempts to summarize patterns in the latest research reports based on the molecular characteristics and regulatory mechanisms of heat shock proteins. From this synthesis, the authors screen for members of the family with potential for diagnosis, accurate tumor staging, future targeted drug design, and development.
On the therapeutic side, the review positions heat shock proteins as candidates for future targeted drug design and development. The authors hope the synthesis will provide ideas for future research on related tumors and their clinical treatments. As an open access article published on 27 October 2026 and shared early to provide faster access to peer-reviewed, accepted research, the review is citable and carries a permanent DOI, though this version remains subject to further edits before the final Version of Record appears.
For researchers and clinicians, the message is that the heat shock protein family sits at a junction between tumor stress adaptation, immune regulation, and treatment resistance. Mapping which members promote or restrain malignancy in specific contexts, the review concludes, could open routes to better diagnostics and more precise anticancer drugs.
Subject of Research: The roles of heat shock proteins in tumor biology and their potential as targets for cancer diagnosis and therapy
Article Title: Functional roles of HSPs in cancer and their therapeutic potential in antitumor treatment
Article References: Yu, Y., Li, S., Fan, H.-R., & Zhou, C.-C. (2026). Functional roles of HSPs in cancer and their therapeutic potential in antitumor treatment. Discover Oncology. https://doi.org/10.1007/s12672-026-06225-0
Image Credits: AI Generated
DOI: 10.1007/s12672-026-06225-0
Keywords: heat shock proteins, HSP90, HSP70, tumor microenvironment, immune escape, epithelial-mesenchymal transition, angiogenesis, metastasis, exosomes, targeted therapy, cancer diagnostics, Discover Oncology
News Source: Nathaniel Bowman. (October 28, 2026). Heat Shock Proteins Shape Cancer Growth and Treatment Resistance. Scienmag.
